B. Riley Securities to Host Precision Oncology & Radiopharma Investor Conference in New York on February 28, 2025
Rhea-AI Summary
B. Riley Securities has announced its upcoming Precision Oncology & Radiopharma Investor Conference, scheduled for February 28, 2025, in New York. The one-day event will showcase over 30 companies focused on next-generation targeted oncology and radiopharmaceutical therapeutics and diagnostics.
The conference will feature research analyst-moderated panels discussing healthcare policy disruptions, radiopharma value chain developments, antibody drug conjugates, T-cell engagers, and synthetic lethality approaches. These emerging modalities have been significant targets in recent pharmaceutical acquisitions.
According to Andy Moore, CEO of B. Riley Securities, the conference brings together industry leaders developing breakthrough therapies, offering investors opportunities to participate in healthcare advancement. The event format includes panels, presentations, fireside chats, and roundtables, with attendance being invitation-only. Interested parties can register by emailing BRSHealthcareEvents@brileyfin.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, RILY gained 10.39%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
This one-day conference will feature more than 30 institutionally relevant companies developing and commercializing next-gen targeted oncology and radiopharmaceutical therapeutics and diagnostics. In addition to investor discussions, B. Riley Equity Research Analysts will be moderating panels covering topics including recent disruptions to healthcare policy, the evolving radiopharma value chain, antibody drug conjugates and T-cell engagers, and novel approaches in synthetic lethality.
The emerging modalities being developed and commercialized by the attending companies have represented an outsized proportion of recent pharma acquisitions. As the field evolves, this conference is bringing together industry leaders for early insight into breakthrough therapies.
Andy Moore, CEO of B. Riley Securities, commented: "We're excited to bring together a curated selection of companies at the forefront of delivering life-saving and critical therapeutic and imaging modalities. Their pursuits are ground-breaking and create an opportunity for investors to participate in the next wave of advancement in healthcare."
The conference will feature a comprehensive schedule, including research analyst-moderated panels, presentations, fireside chats and roundtables.
Participation in the conference is by invitation only. If you are interested in registering for the event, please email BRSHealthcareEvents@brileyfin.com
B. Riley Securities, Inc.
B. Riley has served as a preeminent middle market brokerage and investment banking firm for over 25 years. We provide a full suite of investment banking and capital markets services to companies, financial sponsors, and institutional investors across all industry verticals. Investment banking services include initial, secondary and follow-on offerings, institutional private placements, merger and acquisition (M&A) advisory, SPACs, corporate restructuring and recapitalization. Widely recognized for our thematic proprietary equity research, clients benefit from B. Riley's extensive network, industry expertise, and proven execution capabilities of our end-to-end financial services platform. Please see disclosures about B. Riley Securities Research here. The firm is a subsidiary of B. Riley Financial (Nasdaq: RILY). For more information, visit www.brileysecurities.com.
Contacts
press@brileyfin.com
View original content:https://www.prnewswire.com/news-releases/b-riley-securities-to-host-precision-oncology--radiopharma-investor-conference-in-new-york-on-february-28-2025-302382323.html
SOURCE B. Riley Financial
FAQ
When and where is B. Riley Securities hosting its Precision Oncology Conference in 2025?
How many companies will be presenting at B. Riley's 2025 Oncology Conference?
What key topics will be discussed at B. Riley's 2025 Radiopharma Conference?
How can investors register for B. Riley's 2025 Precision Oncology Conference?
What types of sessions will be featured at B. Riley's 2025 healthcare conference?
